Table 2.
Clinical and Demographic Characteristics
| Characteristic | Risk Group
|
Total
|
||||
|---|---|---|---|---|---|---|
| Early Relapse
|
Late Relapse
|
|||||
| No. | % | No. | % | No. | % | |
| Median age, years | 9.5 | 10.4 | 10.0 | |||
| Range | 1.6-21.4 | 4.3-21.1 | 1.6-21.4 | |||
| Sex | ||||||
| Male | 43 | 62 | 37 | 67 | 80 | 65 |
| Female | 26 | 38 | 18 | 33 | 44 | 35 |
| Immunophenotype | ||||||
| B lineage | 63 | 91 | 54 | 98 | 117 | 94 |
| T lineage | 6 | 9 | 1 | 2 | 7 | 6 |
| Ph+ | ||||||
| No | 67 | 97 | 53 | 96 | 120 | 97 |
| Yes | 2 | 3 | 2 | 4 | 4 | 3 |
| CNS disease | ||||||
| Negative | 63 | 91 | 47 | 85 | 110 | 89 |
| Positive | 6 | 9 | 8 | 15 | 14 | 11 |
| Ph+ and CNS | ||||||
| No | 69 | 100 | 54 | 98 | 123 | 99 |
| Yes | 0 | 0 | 1 | 2 | 1 | 1 |
| Total | 69 | 55 | 124 | |||
Abbreviation: Ph, Philadelphia chromosome.